Reproductive Medicine Associates of Michigan

Troy, Michigan 48084

Medical Director: Brad T. Miller, MD

Reproductive Medicine Associates of Michigan, located in Troy, offers comprehensive fertility care under the guidance of Medical Director Dr. Brad T. Miller. The clinic provides a full range of services including IVF, egg freezing, donor egg programs, and surrogacy support, helping patients navigate their unique paths to parenthood. With a verified lab accreditation, you can feel confident in the quality and safety of your care.

The clinic's success rates reflect their commitment to excellence, with live birth rates of 59.50% for patients under 35 and 44.70% for those ages 35-37. Having completed 1,040 treatment cycles in 2022, the team brings substantial experience to each patient's journey. Understanding that fertility treatment can feel overwhelming, the clinic focuses on providing clear guidance and personalized care tailored to your specific needs. Their comprehensive approach means you can access multiple treatment options under one roof, allowing for continuity of care as your needs evolve throughout the process.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3559.50%+11.154.60%48.4%
35–3744.70%+8.753.80%36%
38–4027.90%+4.339.30%23.6%
Over 405.60%-3.915.40%9.5%

Based on 1,040 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.